pev7b1
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2010 (NCT01067131)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- CandidaImmunity, active
Candida immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pev7b1
- pev7b2
- pev7c1
- pev7c9
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01067131 | Phase 1 | Mar 1, 2010 | Covance, Pevion Biotech Ltd, University of Lausanne |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Covance | For profit | 1 | 0 | 1 | 2010 |
| Pevion Biotech Ltd | For profit | 1 | 1 | 1 | 2010 |
| University of Lausanne | Academic/Hospital | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1